Tavares, C.; Eloy, C.; Melo, M.; Gaspar da Rocha, A.; Pestana, A.; Batista, R.; Bueno Ferreira, L.; Rios, E.; Sobrinho Simões, M.; Soares, P.
mTOR Pathway in Papillary Thyroid Carcinoma: Different Contributions of mTORC1 and mTORC2 Complexes for Tumor Behavior and SLC5A5 mRNA Expression. Int. J. Mol. Sci. 2018, 19, 1448.
https://doi.org/10.3390/ijms19051448
AMA Style
Tavares C, Eloy C, Melo M, Gaspar da Rocha A, Pestana A, Batista R, Bueno Ferreira L, Rios E, Sobrinho Simões M, Soares P.
mTOR Pathway in Papillary Thyroid Carcinoma: Different Contributions of mTORC1 and mTORC2 Complexes for Tumor Behavior and SLC5A5 mRNA Expression. International Journal of Molecular Sciences. 2018; 19(5):1448.
https://doi.org/10.3390/ijms19051448
Chicago/Turabian Style
Tavares, Catarina, Catarina Eloy, Miguel Melo, Adriana Gaspar da Rocha, Ana Pestana, Rui Batista, Luciana Bueno Ferreira, Elisabete Rios, Manuel Sobrinho Simões, and Paula Soares.
2018. "mTOR Pathway in Papillary Thyroid Carcinoma: Different Contributions of mTORC1 and mTORC2 Complexes for Tumor Behavior and SLC5A5 mRNA Expression" International Journal of Molecular Sciences 19, no. 5: 1448.
https://doi.org/10.3390/ijms19051448
APA Style
Tavares, C., Eloy, C., Melo, M., Gaspar da Rocha, A., Pestana, A., Batista, R., Bueno Ferreira, L., Rios, E., Sobrinho Simões, M., & Soares, P.
(2018). mTOR Pathway in Papillary Thyroid Carcinoma: Different Contributions of mTORC1 and mTORC2 Complexes for Tumor Behavior and SLC5A5 mRNA Expression. International Journal of Molecular Sciences, 19(5), 1448.
https://doi.org/10.3390/ijms19051448